Chimerix (CMRX) Tops Q4 EPS by 4c

Chimerix (NASDAQ: CMRX) reported Q4 EPS of ($0.20), $0.04 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $814 thousand versus the consensus estimate of $80 thousand.

For earnings history and earnings-related data on Chimerix (CMRX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results
• Medtronic completes $550 million Scientia Vascular acquisition